Short answer
A biomarker is a measurable characteristic that can indicate a normal biological process, disease process, or response to an exposure or intervention. Emerging biomarker tests can be useful, but a number is not automatically actionable just because it is measurable, trackable, or marketed as “optimization.”
The four-question test
| Question | Why it matters |
|---|---|
| Is it analytically reliable? | The lab, device, or wearable must measure the signal consistently enough to trust changes. |
| Is it clinically meaningful? | The number should connect to health outcomes or validated medical decisions. |
| Is there a useful action? | A test is stronger when it leads to an evidence-based next step. |
| Does acting on it improve outcomes? | Changing a biomarker is not the same as improving symptoms, risk, function, or lifespan. |
Biomarker versus surrogate endpoint
FDA explains that biomarkers can be used in many ways, including identifying patients, monitoring safety, or checking whether an intervention is having a biological effect. A surrogate endpoint goes further: it is used as a substitute for a direct clinical outcome in some research or regulatory settings. Consumers should be cautious when marketing treats an early biomarker as if it proves a real-world health benefit.
Examples that need careful framing
- Continuous glucose patterns in people without diabetes.
- Biological age and epigenetic age reports.
- Hormone panels ordered without symptoms or a clear clinical question.
- Wearable-derived heart-rate variability, recovery, and sleep scores.
- Inflammatory markers used for general wellness tracking.
- Advanced lipid markers such as ApoB and Lp(a) when used outside a clear cardiovascular-risk discussion.
- Nutrition-status markers such as the omega-3 index when marketed as a broad longevity or optimization score.
How Lab Intel will grade emerging tests
| Grade | Meaning |
|---|---|
| Established | Widely used in clinical care with guideline-backed interpretation. |
| Useful with context | Clinically relevant for specific people or situations, but easy to misuse broadly. |
| Promising | Research is active, but consumer action claims are ahead of the evidence. |
| Commercial claim | Marketed as useful without enough independent evidence for medical interpretation. |
What to do before you act on a number
Before changing behavior, buying a repeat panel, or making a medical decision, ask whether the number is reliable, whether it is clinically meaningful, whether there is a proven next step, and whether acting on it actually improves outcomes. If those answers are unclear, the result is usually a conversation starter, not a verdict.
FAQ
What is a biomarker?
FDA describes a biomarker as a defined characteristic measured as an indicator of normal biological processes, disease processes, or responses to an exposure or intervention.
Does changing a biomarker always improve health?
No. A biomarker can be measurable and still not prove that changing it will improve symptoms, disease risk, quality of life, or longevity.
What makes an emerging biomarker hard to trust?
A signal can be measurable but still lack reproducibility, clinical meaning, or evidence that acting on it improves outcomes.
Are wearable or consumer scores automatically medical tests?
No. Some are wellness estimates, some are laboratory tests, and some are early research tools. The intended use matters.
What should I ask before paying for one?
Ask whether the number is analytically reliable, clinically meaningful, actionable, and proven to improve outcomes when acted on.
What if a test changes over time?
Trend data can be useful, but a moving number still needs interpretation in context and does not automatically justify a medical decision.